Pfizer talking with CROs to fill R&D hub

Wednesday, March 16, 2011

A U.K. task force—assembled to salvage as many R&D jobs at Sandwich as it can before Pfizer completes its planned exit—has confirmed that the pharma giant is in discussions with CROs that may step in to hire some of the 2,400 workers being let go, according to Fierce Biotech.

[Read More]

Health Research Bus takes trials on the road

Tuesday, March 15, 2011

A mobile clinical research facility developed in the U.K. as part of an alliance between the Universities of Birmingham and Warwick has started recruiting its first patients in Birmingham for three studies organized by the Wellcome Trust Clinical Research facility at the city’s Queen Elizabeth Hospital, according to Pharma Times.

[Read More]

Arsanis closes Series A financing

Tuesday, March 8, 2011

Arsanis, a new biotechnology company that develops anti-infective monoclonal antibody therapeutics, has closed a Series A financing with a total funding of $10 million. Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.

[Read More]